Nanoscope Therapeutics Announces Presentations in Upcoming ASGCT Annual Meeting and Retina World Congress

/PRNewswire/ -- Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for retinal degenerative diseases, today...

Related Keywords

Dallas ,Texas ,United States ,Gainesville ,Florida ,University Of South Florida ,Maryland ,Fort Lauderdale ,Baltimore ,Peter Kaiser ,Christine Kay ,Samuel Barone ,Samarendra Mohanty ,Prnewswire Nanoscope Therapeutics Inc ,Retina World Congress ,Nanoscope Therapeutics Inc ,Clinical Trials At Vitreoretinal Associates ,Fort Lauderdale Marriott Harbor Beach Hotel ,Therapeutics Inc ,Multi Characteristic Opsin ,Poster Number ,Wednesday Posters ,Gene Therapy Trials ,Chief Medical ,Non Viral Targeted Laser Delivery ,Multi Characteristic Opsin Genes ,Oral Abstract ,Nonviral Approaches ,Therapeutic Applications ,Chief Scientific ,Gene Therapy ,Fort Lauderdale Marriott Harbor Beach ,Cole Eye Institute ,Cleveland Clinic Lerner College ,Safety Analysis ,Therapy For Retinitis Pigmentosa ,Patient Case From ,Assessor Masked Clinical Trial ,Retinal Genetics ,Clinical Trials ,Vitreoretinal Associates ,Affiliate Assistant Professor ,Nanoscope Therapeutics ,